Phase I study of adjuvant chemotherapy with nab-paclitaxel and S-1 for stage III Lauren's diffuse-type gastric cancer after D2 resection (NORDICA study).
Yuehong CuiYiyi YuShan YuWei LiYan WangQian LiTianshu LiuPublished in: Cancer medicine (2022)
. The AS regimen had a tolerable AE profile in stage III DGC.